FSRH CEU statement Levosert 6 year license for contraception - Feb 2021

Published on: 8 February 2021

File size: 378kb PDF

File type: Clinical Statements

This statement notes that the Levosert® 52mg LNG-IUS has been licensed for contraceptive use for 6 years. Levosert remains licensed for 5 years for management of heavy menstrual bleeding and is not licensed for endometrial protection as part of HRT.

Your download should start automatically. If not download directly.